Search research articles
Contact Us
Filters
Showing results (81-90 of 203) with videos related to
Page
of 21
Sort By:
Psychiatry Research
|
February 11, 2017
Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction study
Philip Gerretsen, Hiroyoshi Takeuchi, Miracle Ozzoude, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 12, 2015
Neurocognitive impairment in the deficit subtype of schizophrenia
Gagan Fervaha, Ofer Agid, George Foussias, et al.
Psychiatry and Clinical Neurosciences
|
January 14, 2020
Effectiveness of brexpiprazole in the treatment in a patient with Huntington's disease
Yu Mimura, Michitaka Funayama, Hiroki Oi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 25, 2020
Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, et al.
Schizophrenia Research
|
December 1, 2019
Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms
Yutaro Shimomura, Yuhei Kikuchi, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry
|
May 14, 2021
Single Versus Multiple Daily Dosing Regimens of Psychotropic Drugs for Psychiatric Disorders: A Systematic Review and Meta-Analysis
Yuhei Kikuchi, Yutaro Shimomura, Takefumi Suzuki, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 20, 2017
One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis
Hiroyoshi Takeuchi, Navot Kantor, Marcos Sanches, et al.
Journal of Clinical Psychopharmacology
|
November 12, 2005
Combined treatment with sulpiride and paroxetine for accelerated response in patients with major depressive disorder
Hiroyuki Uchida, Hiroyoshi Takeuchi, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry
|
January 7, 2015
Determinants of patient-rated and clinician-rated illness severity in schizophrenia
Gagan Fervaha, Hiroyoshi Takeuchi, Ofer Agid, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 27, 2014
Relationship between clinical improvement and functional gains with clozapine in schizophrenia
Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 203) with videos related to
Sort By:
Page
of 21
Psychiatry Research
|
February 11, 2017
Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction study
Philip Gerretsen, Hiroyoshi Takeuchi, Miracle Ozzoude, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 12, 2015
Neurocognitive impairment in the deficit subtype of schizophrenia
Gagan Fervaha, Ofer Agid, George Foussias, et al.
Psychiatry and Clinical Neurosciences
|
January 14, 2020
Effectiveness of brexpiprazole in the treatment in a patient with Huntington's disease
Yu Mimura, Michitaka Funayama, Hiroki Oi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
January 25, 2020
Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, et al.
Schizophrenia Research
|
December 1, 2019
Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms
Yutaro Shimomura, Yuhei Kikuchi, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry
|
May 14, 2021
Single Versus Multiple Daily Dosing Regimens of Psychotropic Drugs for Psychiatric Disorders: A Systematic Review and Meta-Analysis
Yuhei Kikuchi, Yutaro Shimomura, Takefumi Suzuki, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 20, 2017
One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis
Hiroyoshi Takeuchi, Navot Kantor, Marcos Sanches, et al.
Journal of Clinical Psychopharmacology
|
November 12, 2005
Combined treatment with sulpiride and paroxetine for accelerated response in patients with major depressive disorder
Hiroyuki Uchida, Hiroyoshi Takeuchi, Takefumi Suzuki, et al.
The Journal of Clinical Psychiatry
|
January 7, 2015
Determinants of patient-rated and clinician-rated illness severity in schizophrenia
Gagan Fervaha, Hiroyoshi Takeuchi, Ofer Agid, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 27, 2014
Relationship between clinical improvement and functional gains with clozapine in schizophrenia
Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Page
of 21